Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Clinical trial NCT05110261 · COMPLETED

Trial details

NCT number: NCT05110261
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lower Respiratory Tract Infection

Start date: 2021-11-24
Primary completion: 2025-11-24
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.